Evidence map›Paper›PMID 29796977›Full record

ArticleCNS drugs2018

Prescription of Zolpidem and the Risk of Fatal Motor Vehicle Collisions: A Population-Based, Case-Crossover Study from South Korea.

Bo Ram Yang, Ye-Jee Kim, Mi-Sook Kim, Sun-Young Jung, Nam-Kyong Choi, Byungkwan Hwang, Byung-Joo Park, Joongyub Lee

Abstract read
PubMed Publisher
In one paragraph

Article in CNS drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Interrupted Time Series Analysis of Changes in Zolpidem Use Due to Media Broadcasts.International journal of environmental research and public health · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Bo Ram YangMedical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.
Ye-Jee KimDepartment of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Republic of Korea.
Mi-Sook KimMedical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea.
Sun-Young JungCollege of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Nam-Kyong ChoiDepartment of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Republic of Korea.
Byungkwan HwangDepartment of Neurology, Texas Tech University Health Science Center, Lubbock, TX, USA.
Byung-Joo ParkDepartment of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Joongyub LeeSchool of Medicine, Inha University, Incheon, Republic of Korea. tp240@naver.com.ORCID http://orcid.org/0000-0003-2784-3772

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZolpidem is one of the most frequently used hypnotics worldwide, but associations with serious adverse effects such as motor vehicle collisions have been reported.

objectiveThe objective of this study was to evaluate the association of fatal motor vehicle collisions with a prescription for zolpidem, considering the context of the motor vehicle collisions.

methodsWe conducted a case-crossover study, where each case served as its own control, by linking data about fatal motor vehicle collisions from the Korean Road Traffic Authority between 2010 and 2014 with national health insurance data. The case period was defined as 1 day before the fatal motor vehicle collisions, and was matched to four control periods at 90-day intervals. Conditional logistic regression was performed to calculate the odds ratio for fatal motor vehicle collisions associated with zolpidem exposure, and odds ratios were adjusted for time-varying exposure to confounding medications. A stratified analysis was performed by age group (younger than 65 years or not), the Charlson Comorbidity Index, and whether patients were new zolpidem users.

resultsAmong the 714 subjects, the adjusted odds ratio for a fatal motor vehicle collision associated with a prescription for zolpidem the previous day was 1.48 (95% confidence interval 1.06-2.07). After stratification, a significantly increased risk was observed in subjects with a high Charlson Comorbidity Index (odds ratio 1.81; 95% confidence interval 1.16-2.84), the younger age group (odds ratio: 1.62; 95% confidence interval 1.03-2.56), and new zolpidem users (odds ratio 2.37; 95% confidence interval 1.40-4.00).

conclusionA prescription for zolpidem on the previous day was significantly related to an increased risk of fatal motor vehicle collisions in this population-based case-crossover study.

Indexed as

Accidents, TrafficAgedAge FactorsCase-Control StudiesCommunity Health PlanningDrug PrescriptionsFemaleHumansIncidenceMaleMiddle AgedRepublic of KoreaRetrospective StudiesSleep Aids, PharmaceuticalZolpidemSleep Aids, PharmaceuticalZolpidem

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.